Teresa Mattarelli
Corporate Officer/Principal en Perspectum Group Ltd. .
Perfil
Teresa Mattarelli is currently the Chief Commercial Officer at Perspectum Group Ltd.
Prior to this, she worked at Medtronic Plc as the Global Vice President & General Manager from 2019 to 2020.
She completed her undergraduate degree and MBA from McGill University.
Cargos activos de Teresa Mattarelli
| Empresas | Cargo | Inicio |
|---|---|---|
Perspectum Group Ltd.
 Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 01/02/2021 |
Antiguos cargos conocidos de Teresa Mattarelli.
| Empresas | Cargo | Fin |
|---|---|---|
| MEDTRONIC PLC | Corporate Officer/Principal | 01/11/2020 |
Formación de Teresa Mattarelli.
| McGill University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MEDTRONIC PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Technology Services |
- Bolsa de valores
- Insiders
- Teresa Mattarelli
